Gaps Identified in Medicaid Provision of Routine Vision Care
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, Aug. 9, 2024 -- Although most fee-for-service Medicaid programs cover routine eye exams, many do not cover glasses or low vision aids, according to a study published in the August issue of Health Affairs.
Brandy J. Lipton, Ph.D., from the University of California in Irvine, and colleagues detailed Medicaid policies for 2022 and documented variability in coverage for adult vision services by state.
The researchers found that routine eye exams were covered by most fee-for-service Medicaid programs, although many did not cover glasses or low vision aids (20 and 35 states, respectively). Enrollee cost sharing was required by about two-thirds of states with routine coverage. Relative to fee-for-service programs, managed care plans generally provided consistent or enhanced coverage, although sometimes there was between-plan variation in coverage within a state. About 6.5 and 14.6 million adult enrollees were estimated to reside in states without comprehensive coverage for routine eye exams and glasses, respectively.
"Our study clearly shows that there are opportunities to expand coverage of routine vision services at the state level, and based on previous research, we expect more generous coverage would reduce rates of vision impairment, improve quality of life, and promote health equity," Lipton said in a statement.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-08-10 01:15
Read more
- Infectious Diseases Society of America, Oct. 16-19
- Long-Term Upadacitinib Use Feasible for Adolescents With Atopic Dermatitis
- LENZ Therapeutics Announces FDA Acceptance of New Drug Application for LNZ100 for the Treatment of Presbyopia
- Vitamin D Supplements Could Help Lower Blood Pressure in Obese People
- Antiviral Treatment Underutilized for Children, Teens With Flu
- Dose-Dependent Association Seen for Smoking, CVD Risk
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions